Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results.
Journal: JCO oncology advances
Published: November 06, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 05, 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 02, 2024
Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case series.
Journal: Pediatric blood & cancer
Published: December 07, 2023
Chromoplexy Is a Frequent Early Clonal Event in EWSR1-Rearranged Round Cell Sarcomas That Can Be Detected Using Clinically Validated Targeted Sequencing Panels.
Journal: Cancer research
Published: August 25, 2023
Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials.
Journal: Pediatric blood & cancer
Published: July 28, 2023
Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
Journal: Cancer research
Published: February 17, 2023
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma.
Journal: bioRxiv : the preprint server for biology
Published: January 30, 2023
Deep Learning-Based Objective and Reproducible Osteosarcoma Chemotherapy Response Assessment and Outcome Prediction.
Journal: The American journal of pathology
Published: October 23, 2022
Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance.
Journal: JCO precision oncology
Published: August 11, 2022
Irinotecan dose schedule for the treatment of Ewing sarcoma.
Journal: Pediatric blood & cancer
Published: June 30, 2022
Last Updated: 09/26/2026